Patents Assigned to USA Elixiria Biotech Inc.
  • Publication number: 20230322692
    Abstract: The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.
    Type: Application
    Filed: May 19, 2023
    Publication date: October 12, 2023
    Applicant: USA Elixiria Biotech Inc.
    Inventors: Lihai ZHANG, Min Hu